Pankaj Pal, Ph.D.
|2015||Biology and Biomedical Sciences (Molecular Microbiology and Microbial Pathogenesis)||Washington University, Saint Louis, St. Louis, MO|
Mean distance: 18.92 (cluster 11)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Pal P, Daniels BP, Oskman A, et al. (2016) Plasmodium falciparum Histidine-Rich Protein II Compromises Brain Endothelial Barriers and May Promote Cerebral Malaria Pathogenesis. Mbio. 7|
|Smith SA, Silva LA, Fox JM, et al. (2015) Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus. Cell Host & Microbe. 18: 86-95|
|Pal P, Fox JM, Hawman DW, et al. (2014) Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes. Journal of Virology. 88: 8213-26|
|Hawman DW, Stoermer KA, Montgomery SA, et al. (2013) Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response. Journal of Virology. 87: 13878-88|
|Pal P, Dowd KA, Brien JD, et al. (2013) Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus. Plos Pathogens. 9: e1003312|
|Sun S, Xiang Y, Akahata W, et al. (2013) Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralization. Elife. 2: e00435|